ClearPoint Neuro (CLPT) Convertible Debt (2011 - 2012)
ClearPoint Neuro (CLPT) posted Convertible Debt of $2.0 million for Q4 2012, little changed sequentially from $2.0 million in Q3 2012, and down 39.55% YoY from $3.3 million in Q1 2012.
ClearPoint Neuro (CLPT) Convertible Debt (2011 - 2012) Analysis & Trends
ClearPoint Neuro has reported Convertible Debt for 2 years, with the latest figure at $2.0 million in Q4 2012.
- Quarterly Convertible Debt fell 39.55% year-over-year to $2.0 million in Q4 2012, while the trailing twelve-month figure through Dec 2012 was $2.0 million (down 39.55% YoY) and the FY2012 annual result came in at $2.0 million, down 39.55% from the prior year.
- Convertible Debt held at $2.0 million in Q4 2012 per CLPT's latest filing, from $2.0 million in the prior quarter.
- Over five years, Convertible Debt peaked at $3.3 million in Q4 2011 and troughed at $2.0 million in Q1 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn |
| 10 | ClearPoint Neuro | 465.92 Mn | 436.52 Mn | 6.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 2.00 Mn |
| Sep 30, 2012 | 2.00 Mn |
| Jun 30, 2012 | 2.00 Mn |
| Mar 31, 2012 | 2.00 Mn |
| Dec 31, 2011 | 3.31 Mn |